V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002083 | 330001180 | 0 | 51 | Curative (C) | null | 2016-01-23 | CNS LGG2004 03 vinc + carbo | Y | N | 330007899 | NOT MATCHED |
| 330002084 | 330006634 | null | 96 | Curative (C) | 2014-03-23 | 2014-04-19 | Cisplatin 7 day | N | N | 330007900 | CISPLATIN |
| 330002085 | 330006634 | 1.6 | 22.1 | Curative (C) | 2016-09-22 | 2016-09-22 | EW EuroEwing 2012 Arm B VDC | Y | N | 330007900 | TRIAL |
| 330002086 | 330001181 | null | 84.6 | Curative (C) | 2017-05-31 | 2017-05-31 | NB HRNBL-1 Isotretinoin | N | null | 330007905 | NOT MATCHED |
| 330002087 | 330001181 | 0 | 81.2 | Curative (C) | 2018-09-13 | 2018-09-26 | NB HRNBL-1 COJEC Ind COURSE A | 01 | N | 330007905 | NOT MATCHED |
| 330002088 | 330001181 | 1.68 | 47.2 | Curative (C) | 2017-10-17 | 2017-10-23 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330007905 | NOT MATCHED |
| 330002089 | 330001181 | null | 68 | Curative (C) | 2017-09-04 | 2017-10-03 | Cisplatin | N | Y | 330007905 | CISPLATIN |
| 330002090 | 330001181 | null | 66.45 | Curative (C) | 2015-01-03 | 2015-01-03 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007905 | NOT MATCHED |
| 330002091 | 330001181 | 0 | 38.7 | Curative (C) | 2017-06-04 | 2017-06-22 | EW EuroEwing 2012 Arm B VDC | Y | N | 330007905 | TRIAL |
| 330002092 | 330001182 | 1.64 | 89 | Curative (C) | 2013-04-18 | 2013-05-02 | Cisplatin | null | null | 330007931 | CISPLATIN |
| 330002093 | 330001183 | 1.55 | 58.7 | Curative (C) | null | 2014-11-05 | Cisplatin | 02 | Y | 330007934 | CISPLATIN |
| 330002094 | 330001183 | 1.52 | 65 | Neo-adjuvant (N) | 2013-05-04 | 2013-05-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330007934 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002095 | 330001183 | 1.62 | 113.55 | Curative (C) | 2014-07-08 | 2014-07-09 | NB HRNBL-1 COJEC Ind COURSE A | N | null | 330007934 | NOT MATCHED |
| 330002096 | 330001184 | null | 74.5 | Neo-adjuvant (N) | 2016-09-19 | 2016-10-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007962 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002097 | 330001185 | null | 65.9 | Curative (C) | 2016-06-17 | 2016-06-19 | NB HRNBL-1 COJEC Ind COURSE A | 01 | N | 330007969 | NOT MATCHED |
| 330002098 | 330001185 | 1.92 | 69.9 | Curative (C) | 2014-06-08 | 2014-06-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007969 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002099 | 330001185 | 1.78 | null | Neo-adjuvant (N) | 2014-11-14 | 2014-11-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007969 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002100 | 330001186 | null | 66.6 | Curative (C) | 2016-07-23 | 2016-07-26 | STS Rhabdomyosarco RMS 2005 IVADoVV | Y | N | 330007975 | NOT MATCHED |
| 330002101 | 330001187 | 1.8 | 17.6 | null | 2015-08-27 | 2015-09-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007980 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002102 | 330006638 | 1.74 | 88 | Curative (C) | 2014-09-13 | 2014-09-13 | Cisplatin 7 day | 02 | Y | 330007981 | CISPLATIN |
| 330002103 | 330006638 | 1.64 | 58.8 | Curative (C) | 2015-09-17 | 2015-10-19 | Cisplatin | N | Y | 330007981 | CISPLATIN |
| 330002104 | 330006638 | 1.73 | null | null | 2014-07-16 | 2014-07-22 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007981 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002105 | 330001188 | 1.74 | 89.6 | Curative (C) | null | 2014-12-06 | OST Euramos 1 Closed Trial - Ai | N | N | 330007993 | NOT MATCHED |
| 330002106 | 330006639 | 1.7 | 10.6 | Not known (9) | 2013-01-31 | 2013-01-31 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330007995 | TRIAL |
| 330002107 | 330001189 | 1.66 | 65.2 | Curative (C) | 2017-02-08 | 2017-02-08 | NB Rel CCLG guidelines Cyclo-Topotecan | null | N | 330008004 | NOT MATCHED |
| 330002108 | 330006640 | 1.5 | 57 | Curative (C) | 2016-12-02 | 2017-01-11 | Cisplatin 7 day | N | N | 330008007 | CISPLATIN |
| 330002109 | 330006640 | null | 92 | Curative (C) | 2015-01-28 | 2015-01-29 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | Y | N | 330008007 | NOT MATCHED |
| 330002110 | 330006640 | null | 10 | null | 2016-06-25 | 2016-06-28 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330008007 | NOT MATCHED |
| 330002111 | 330001190 | 1.78 | null | Curative (C) | 2013-04-13 | 2013-04-13 | Trial Unspecified | N | N | 330008011 | TRIAL |
| 330002112 | 330001190 | 0 | 50.4 | Curative (C) | 2016-07-09 | 2016-07-10 | CNS LGG 2004 03 cons vinc + carbo | Y | N | 330008011 | NOT MATCHED |
| 330002113 | 330001190 | 1.81 | null | Adjuvant (A) | 2016-05-25 | 2016-06-09 | Cisplatin | N | Y | 330008011 | CISPLATIN |
| 330002114 | 330001191 | 1.7 | 63.9 | Curative (C) | 2013-06-26 | 2013-07-03 | Cisplatin | N | Y | 330008018 | CISPLATIN |
| 330002115 | 330001191 | 1.73 | 100.3 | Curative (C) | 2016-12-29 | 2017-01-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330008018 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002116 | 330001191 | 1.8 | null | Disease modification (D) | 2018-08-12 | 2018-08-25 | Trial Unspecified | 01 | N | 330008018 | TRIAL |
| 330002117 | 330001192 | null | 51.1 | Curative (C) | 2014-07-11 | 2014-07-31 | Trial Unspecified | null | N | 330008032 | TRIAL |
| 330002118 | 330006643 | null | 22.1 | Curative (C) | 2013-10-21 | 2013-10-21 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330008033 | NOT MATCHED |
| 330002119 | 330001193 | 1.67 | 74.9 | Neo-adjuvant (N) | 2015-10-15 | 2015-10-28 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330008035 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002120 | 330001193 | 1.8 | 27.3 | Curative (C) | 2016-05-28 | 2016-06-24 | Cisplatin | N | Y | 330008035 | CISPLATIN |
| 330002121 | 330001193 | 1.7 | 21.8 | Neo-adjuvant (N) | 2016-08-17 | 2016-08-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008035 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002122 | 330001194 | 1.6 | 32.5 | null | 2016-12-12 | 2016-12-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 330008039 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002123 | 330001194 | null | 94.6 | Curative (C) | 2017-02-10 | 2017-02-19 | CNS PNET III Vinc, Carbo, Etoposide | N | N | 330008039 | NOT MATCHED |
| 330002124 | 330001194 | 1.8 | 99.2 | Adjuvant (A) | 2013-10-05 | 2013-11-01 | Cisplatin | N | Y | 330008039 | CISPLATIN |
| 330002125 | 330001195 | 1.67 | 65.8 | Neo-adjuvant (N) | null | 2016-02-23 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330008046 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002126 | 330001195 | 1.65 | 59 | Neo-adjuvant (N) | 2013-10-27 | 2013-11-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008046 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002127 | 330001195 | 1.54 | 87.9 | Curative (C) | 2017-12-17 | 2018-01-10 | Cisplatin | N | N | 330008046 | CISPLATIN |
| 330002128 | 330001196 | 1.73 | null | Palliative (P) | 2013-05-26 | 2013-06-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008050 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002129 | 330001196 | 1.01 | null | Curative (C) | 2014-08-24 | 2014-09-17 | Trial Unspecified | Y | N | 330008050 | TRIAL |
| 330002130 | 330001196 | null | 62.1 | Curative (C) | 2015-01-25 | 2015-02-18 | EW Rel rEECur Topotecan/Cyclophosphamide | Y | N | 330008050 | NOT MATCHED |
| 330002131 | 330001196 | 1.67 | null | Neo-adjuvant (N) | 2016-11-14 | 2016-11-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330008050 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002132 | 330001196 | null | null | Curative (C) | 2015-09-28 | 2015-09-28 | ALL Interfant 06 Ind d 1-7 Pred | 01 | N | 330008050 | NOT MATCHED |